InvestorsHub Logo

Bourbon_on_my_cornflakes

09/15/23 3:31 PM

#430833 RE: ignatiusrielly35 #430831

A $5 billion offer would take this company out.

It could happen if Rett results are clear and unambiguously good.

Market attributes little value to alz ans sees it as 4-5 years away. Lack of movement on yesterdays news makes this clear.

ExtremelyBullishZig

09/15/23 3:37 PM

#430835 RE: ignatiusrielly35 #430831

$5B isn't a discount if not approved. They are all a shot in the dark until they are not. Every biotech company has drugs in the pipeline with plans for approval. Unfortunately, most don't make it...even after a buyout...I guess the buyer overpaid in those instances.